Search Results (37)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Antifungal Triazole Posaconazole Targets an Early Stage of the Parechovirus A3 Life Cycle. | Academic Article |
Why?
|
| Development and Application of a High-Throughput Screening Method to Evaluate Antifungal Activity against Trichophyton tonsurans. | Academic Article |
Why?
|
| Inhibition of nucleotide biosynthesis potentiates the antifungal activity of amphotericin B. | Academic Article |
Why?
|
| Oral terbinafine: a new antifungal agent. | Academic Article |
Why?
|
| Variability in Antifungal and Antiviral Use in Hospitalized Children. | Academic Article |
Why?
|
| Voriconazole: a new triazole antifungal. | Academic Article |
Why?
|
| Characteristics of antifungal utilization for hospitalized children in the United States. | Academic Article |
Why?
|
| Antifungal Agents | Concept |
Why?
|
| Prospective CYP2C19-Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations. | Academic Article |
Why?
|
| Antifungal azoles itraconazole and posaconazole exhibit potent in vitro antiviral activity against clinical isolates of parechovirus A3 (Picornaviridae). | Academic Article |
Why?
|
| Efficacy of itraconazole in children with Trichophyton tonsurans tinea capitis. | Academic Article |
Why?
|
| Investigation of terbinafine as a CYP2D6 inhibitor in vivo. | Academic Article |
Why?
|
| Peritoneal penetration of amphotericin B lipid complex and fluconazole in a pediatric patient with fungal peritonitis. | Academic Article |
Why?
|
| Pharmacokinetic considerations in treating invasive pediatric fungal infections. | Academic Article |
Why?
|
| Pharmacokinetics of terbinafine in young children treated for tinea capitis. | Academic Article |
Why?
|